Tian J, Lehmann P V, Kaufman D L
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California 90095-1735, USA.
J Exp Med. 1997 Dec 15;186(12):2039-43. doi: 10.1084/jem.186.12.2039.
The nature (Th1 versus Th2) and dynamics of the autoimmune response during the development of insulin-dependent diabetes mellitus (IDDM) and after immunotherapy are unclear. Here, we show in nonobese diabetic (NOD) mice that the autoreactive T cell response starts and spreads as a pure Th1 type autoimmunity, suggesting that a spontaneous Th1 cascade underlies disease progression. Surprisingly, induction of antiinflammatory Th2 responses to a single beta cell antigen (betaCA) resulted in the spreading of Th2 cellular and humoral immunity to unrelated betaCAs in an infectious manner and protection from IDDM. The data suggest that both Th1 and Th2 autoimmunity evolve in amplificatory cascades by generating site-specific, but not antigen-specific, positive feedback circuits. Determinant spreading of Th2 responses may be a fundamental mechanism underlying antigen-based immunotherapeutics, explaining observations of infectious tolerance and providing a new theoretical framework for therapeutic intervention.
在胰岛素依赖型糖尿病(IDDM)发展过程中以及免疫治疗后自身免疫反应的性质(Th1 与 Th2)和动态尚不清楚。在此,我们在非肥胖糖尿病(NOD)小鼠中表明,自身反应性 T 细胞反应作为一种纯粹的 Th1 型自身免疫开始并扩散,这表明自发的 Th1 级联反应是疾病进展的基础。令人惊讶的是,针对单一β细胞抗原(βCA)诱导抗炎性 Th2 反应导致 Th2 细胞和体液免疫以感染性方式扩散到不相关的βCA,并预防 IDDM。数据表明,Th1 和 Th2 自身免疫均通过产生位点特异性而非抗原特异性的正反馈回路在放大级联反应中演变。Th2 反应的决定簇扩散可能是基于抗原的免疫治疗的基本机制,解释了感染性耐受的观察结果,并为治疗干预提供了新的理论框架。